5nance5nance
5nance5nance
HomeScreens
LOGINGET FREE ACCOUNT

Suraksha Diagnostic Ltd.

•
surakshanet.comBSE: 544293NSE: SURAKSHA
Market Cap₹ 1,763 Cr.
Current Price
High / Low₹ 349 / 224
Stock P/E47.9
Book Value₹ 50
Price to Book6.27
Dividend Yield0.15 %
ROCE25.8 %
ROE17.0 %
Face Value₹ 2

Add ratio to table

ABOUT

AI Sector View

AI GENERATED

Healthcare

Buy

This stance relies on proxies and positioning because no direct pharma-export or healthcare operating series exists in the dataset. The depreciated currency at 95.23 (Sep/26) can support export earnings, inflation at 4.45% (Jul/26) is manageable for a defensive sector, and consumer spending remains large at INR 44743 billion (Jun/26). Strong FPI inflow of INR 10620 crore over 3 months to 2026-08-31 from INR -11381 crore in the prior 3 months adds a real sector-specific tailwind, but confidence stays capped because the fundamental drivers are indirect proxies.

Confidence
50%
View full sector analysis →

PROS

  • Company is almost debt free
  • Operating margins have improved to 33.4% from 22.6%
  • Latest quarter profit grew 27.7% YoY, showing strong momentum
  • Strong cash generation - operating cash flow backs reported profits (CFO/PAT 2.60x)
  • Working capital cycle has improved - days down from 53 to 9
  • Company generates healthy free cash flow

CONS

  • Receivables are growing faster than sales - a possible quality concern
  • Promoter holding has decreased over last 2 years: -13.9pp
  • Equity base is being diluted - shares outstanding up 51.0%
  • Stock is trading at 6.3x its book value
  • Expensive relative to growth - PEG of 4.0

* The pros and cons are machine generated based on quantitative rules.

Peer comparison

HealthcareHealthcareHospital & Healthcare Services
Part ofNIFTY 50NIFTY 500NIFTY LARGEMIDCAP 250NIFTY 100NIFTY 200
S.No.Name
1.APOLLOHOSP8784.0060.45126300.440.23610.4038.417043.5020.5621.7315.70
2.MAXHEALTH994.2066.4296763.150.20322.964.872366.1716.7014.9725.29
3.MANIPALHOS726.00107.0295496.380.002434.30—30906.30—13.9323.83
4.FORTIS912.6565.7568901.260.11272.802.262545.0317.4614.0721.28
5.ASTERDM786.90215.2468591.900.0029.28-68.701310.6821.6011.4619.53
6.NH1880.9547.1038439.250.24207.275.372683.6378.0516.2017.43
7.MEDANTA1418.8568.5938148.870.04157.25-1.091304.0526.5019.3821.99
8.LALPATHLAB1921.9059.5332258.861.071705.001172.397977.001090.9529.5631.03
9.KIMS767.40157.7632231.300.0037.40-56.001179.5035.3311.5119.03
10.AGARWALEYE512.55109.5216249.180.00550.201345.616140.201159.7316.1427.75
11.VIJAYA1505.9582.7315510.940.1353.1037.61230.9822.8330.2842.66
12.SURAKSHA338.4549.241762.670.1512.8440.0087.6520.7424.9234.73
Detailed Comparison with:

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
605155606659647076767984
393635394240444652525569
Operating Profit211620212418202424232415
OPM %35.07%30.26%35.98%34.92%35.75%30.89%30.91%33.92%31.43%30.68%30.31%17.42%
110111111112
Interest222222233344
Depreciation8889999910101111
Profit before Tax1171011148101313111116
Tax %24.04%24.27%29.85%25.76%24.19%24.47%20.22%24.92%25.54%25.80%36.46%22.39%
Net Profit957811681098713
1.620.921.281.562.021.221.541.891.801.561.292.42

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025TTM
99124132151157140223190219249314
77101105116123117175145147166229
Operating Profit2223273534234845728386
OPM %22.25%18.29%20.49%23.11%21.65%16.18%21.54%23.94%32.93%33.42%27.22%
11112124345
Interest45432221010913
Depreciation911121213161532333541
Profit before Tax1081221216338334450
Tax %45.03%42.90%28.98%18.39%27.61%-0.96%28.45%8.67%25.44%23.76%26.87%
Net Profit64817156247243337
EPS0.000.000.000.00178.0076.00278.491.35353.396.42—
Dividend Payout %0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%—

COMPOUNDED SALES GROWTH

10 Years:
14%
5 Years:
10%
3 Years:
4%

COMPOUNDED PROFIT GROWTH

10 Years:
16%
5 Years:
17%
3 Years:
12%

STOCK PRICE CAGR

10 Years:
—
5 Years:
—
3 Years:
—
1 Year:
10%

RETURN ON EQUITY

10 Years:
12%
5 Years:
12%
3 Years:
12%
Last Year:
17%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Corporate actions

2026

Sep 15

₹ 0.25

Rs.0.5000 per share(25%)Final Dividend

2026

Aug 25

₹ 0.25

Rs.0.5000 per share(25%)Final Dividend

Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
77777777710
47717996111118141148172204
3331122081619867574
Trade Payables1081211131314141414
32313528341719273331
Total Liabilities128148145162173171201282302333
919996127128119119195211215
Capital Work in Progress0460001215
318102560013
4446546678
00000000915
Cash & Bank9683443555316
21162124303871232071
Total Assets128148145162173171201282302333

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
16242342382547526163
Cash from Investing-26-38-2-30-20-28-44-22-35-39
Cash from Financing1012-17-7-1031-24-26-24
-3-32-11-1-0-10-1

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
PER SHARE
EPS (₹)79.7664.59121.85247.31220.4893.83344.22104.19353.396.42
Book Value (₹)775.671122.821244.671491.981712.461806.302150.512246.322597.6341.11
Dividend per Share (₹)0.000.000.000.000.000.000.000.000.000.00
Cash EPS (₹)212.79227.52292.89427.49403.02321.54562.93562.65825.3813.09
PROFITABILITY
Operating Margin %23.45%19.16%21.32%24.01%22.63%17.16%22.58%25.82%32.93%33.42%
Net Margin %5.55%3.61%6.37%11.30%9.66%4.62%10.64%3.78%11.16%13.42%
ROE %10.84%6.80%10.29%18.07%13.76%5.33%17.40%4.74%14.59%17.00%
ROCE %16.12%11.59%13.71%20.08%17.99%6.07%22.65%10.26%23.48%25.83%
4.69%3.23%5.74%11.13%9.10%3.76%12.78%2.98%8.35%10.53%
EFFICIENCY
Debtor Days13121214141611121218
Inventory Days1112121213139121111
Payable Days29119321521420918280185189178
-266-170-191-188-181-153-60-161-167-150
FINANCIAL HEALTH
Debt to Equity (x)0.77x0.49x0.29x0.19x0.10x0.13x0.13x0.09x0.05x0.03x
Interest Coverage (x)3.46x2.69x4.01x8.16x11.33x4.37x16.78x1.82x4.42x5.85x
0.73x1.20x1.01x0.79x0.83x1.09x0.78x1.78x1.80x1.16x
GROWTH
Revenue Growth %41.20%24.60%6.83%14.45%4.28%-11.11%59.42%-14.88%15.02%13.99%
Operating Profit Growth %24.39%1.81%18.85%28.91%-1.71%-32.59%109.71%-2.63%54.12%15.90%
Net Profit Growth %-27.64%-19.02%88.65%102.97%-10.85%-57.44%266.84%-69.73%239.18%37.14%
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%239.18%-98.18%
VALUATION
P/E (x)0.00x0.00x0.00x0.00x0.00x0.00x0.00x0.00x0.00x40.15x
P/B (x)0.00x0.00x0.00x0.00x0.00x0.00x0.00x0.00x0.00x6.27x
Dividend Yield %0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
0.00x0.00x0.00x0.00x0.00x0.00x0.00x0.00x-0.47x15.21x

Shareholding Pattern

Numbers in percentages

Mar 2022Mar 2023Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
62.9662.9648.7848.7848.8848.9849.0049.1049.10
0.000.0015.3914.4613.9513.7313.4613.4613.47
0.000.0020.4322.0522.3721.9822.5723.1423.22
Government0.000.000.000.000.000.000.000.000.00
37.0437.0415.3914.7014.8015.3114.9814.3114.21

Documents

Corporate disclosures, annual reports, credit ratings, and concall transcripts

2026-08-31
Copy of Newspaper Publication

2026-08-31 - Suraksha Diagnostic Limited has informed the Exchange about Copy of Newspaper Publication published today, i.e. on Monday, 31 August, 2026 with respect to the Notice of the 21st Annual General Meeting of the Company scheduled to be held on Tuesday, 22 September, 2026 and e-voting information.

2026-08-27
General Updates

2026-08-27 - Pursuant to Regulation 36(1)(b) of the SEBI Listing Regulations, a letter to those Members whose e-mail addresses are not registered with the Company/Registrar and Share Transfer Agent (RTA), i.e. KFin Technologies Limited/Depository Participants (DPs)/Depositories is being dispatched by the Company.

2026-08-27
Shareholders meeting

2026-08-27 - Notice of 21st Annual General Meeting to be held on September 22, 2026.

2026-08-25
Copy of Newspaper Publication

2026-08-25 - Suraksha Diagnostic Limited has informed the Exchange about Copy of Newspaper Publication

2026-08-25
Copy of Newspaper Publication

2026-08-25 - Suraksha Diagnostic Limited has informed the Exchange about Copy of Newspaper Publication

2026-08-17
Analysts/Institutional Investor Meet/Con. Call Updates

2026-08-17 - Suraksha Diagnostic Limited has informed the Exchange about Transcript

2026-08-17
Analysts/Institutional Investor Meet/Con. Call Updates

2026-08-17 - Suraksha Diagnostic Limited has informed the Exchange about Transcript

2026-08-13
Analysts/Institutional Investor Meet/Con. Call Updates

2026-08-13 - Suraksha Diagnostic Limited has informed the Exchange about Link of Recording

2026-08-13
Analysts/Institutional Investor Meet/Con. Call Updates

2026-08-13 - Suraksha Diagnostic Limited has informed the Exchange about Link of Recording

News

Recent coverage and analyst commentary for SURAKSHA

Loading news…

🤖

AI Stock Analyst

Suraksha Diagnostic Ltd.

🔒

Sign in to Chat with AI

Log in with your 5nance account to ask institutional questions about performance, financials, and outlook.

✨ Sign In to Chat

Free 5nance Account

5nance5nance

Stock analysis and screening tool

5nanceAI © 2020-2026

Made with ❤️ in India.

Data provided by Accord Fintech

Terms & Privacy.

Product

PremiumWhat's new?Learn

Team

About usSupport

Theme

5nance5nance

Product

PremiumWhat's new?Learn

Team

About usSupport

Theme


5nanceAI © 2020-2026

Data provided by Accord Fintech

Made with ❤️ in India.

HomeScreens
Login